Global Worker Confidence Plunges to Historic Low Amid AI Job Disruption Fears US Real GDP Per Capita by State Key Economic Variations in 2025 Fragmented HR Systems May Be Costing US Companies Millions in Payroll Errors Tipco Engineering Posts More Than Double Net Profit on Robust Demand Revenue Surges 66 Lowes LOW Faces Reduced Price Target at RBC Capital Tax Season 2025 New Rules for Online Sellers and EV Buyers Could Mean Savings KR Q1 2026 Earnings EPS Beats Estimates Stock Declines 4 Despite Strong Core Performance BBAI Q1 2026 Earnings EPS Misses Estimates Amid Challenging Quarter RILYK Q1 2024 Earnings A Quarter of Continued Losses and Modest Stock Uptick Nortech Systems NSYS Q3 2025 Earnings Loss Per Share Reported Amid Modest Stock Gain CISS Q3 2025 Earnings Loss Per Share of 058 as Shipping Headwinds Persist Stock Declines 339 SMJ International Holdings SMJF Rallies 234 as Stock Approaches Resistance at 505 Riley Exploration Permian REPX Rises 288 as Oil Prices and Sector Momentum Fuel Gains Prudential Financial Subordinated Notes PRS Hold Steady at 2252 as Yield Attracts Income Seekers Diamondback Energy FANG Holds Steady Near Resistance After Modest Decline Real Asset Acquisition Corp Unit RAAQU Drops Over 6 Key Levels to Watch Earning Season in Focus RVNL Suzlon ONGC IRCTC GMR Airports and IndiGo Report Q4 Results Next Week CGBD Q1 2026 Earnings Earnings Slightly Miss Estimates as Stock Declines Kenon Holdings Surges Analyzing the 384 Uptick and Key Levels Lakeland Financial Corporation Q1 2026 Earnings EPS Slightly Beats Estimates Amidst Flat Revenue Environment GOODN Q1 2026 Earnings Preferred Stock Reports Strong EPS Surprise Gen Digital Inc GENVR Q1 2026 Earnings EPS Beat Driven by Operational Discipline Prelude Therapeutics Q1 2026 Earnings Significant EPS Beat Amid No Revenue Energy Transfer ET Q1 2026 Earnings EPS Miss Slightly Shares Edge Higher Amid Operational Strength Commerce Bancshares Inc CBSH Q1 2026 Earnings EPS Beats Estimates by 71 Amid Stable Revenue Trends Savara Inc SVRA Q1 2026 Earnings WiderThanExpected Loss as PreRevenue Biotech Advances Pipeline